Wai Bio Logics is representing the Republic of Korea antibody company specialized in antibody drug since its inception has focused on research and development.
Based on the research and development that began in 2007, we have successfully built our unique human antibody library Y-max ABL, a new dual antibody platform technology ALiCE, and based on this, we have developed a variety of new antibody drugs to become a leader in the global market for cancer drugs. Every effort is made to leap.
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.